Cargando…

Progress and challenges in TB vaccine development

The Bacille Calmette Guerin (BCG) vaccine can provide decades of protection against tuberculosis (TB) disease, and although imperfect, BCG is proof that vaccine mediated protection against TB is a possibility. A new TB vaccine is, therefore, an inevitability; the question is how long will it take us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Voss, Gerald, Casimiro, Danilo, Neyrolles, Olivier, Williams, Ann, Kaufmann, Stefan H.E., McShane, Helen, Hatherill, Mark, Fletcher, Helen A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850090/ https://www.ncbi.nlm.nih.gov/pubmed/29568497 http://dx.doi.org/10.12688/f1000research.13588.1

Ejemplares similares

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
por: McShane, Helen, et al.
Publicado: (2016)

Towards new TB vaccines
por: Brazier, Benedict, et al.
Publicado: (2020)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data()
por: McShane, Helen, et al.
Publicado: (2014)

A New Vaccine for Tuberculosis: The Challenges of Development and Deployment
por: Fletcher, Helen A., et al.
Publicado: (2009)

Aerosol immunisation for TB: matching route of vaccination to route of infection
por: Manjaly Thomas, Zita-Rose, et al.
Publicado: (2015)

TB vaccine development: where are we and why is it so difficult?
por: Wilkie, Morven E M, et al.
Publicado: (2015)

A review of clinical models for the evaluation of human TB vaccines
por: O'Shea, Matthew K., et al.
Publicado: (2016)

Preclinical Development of an In Vivo BCG Challenge Model for Testing Candidate TB Vaccine Efficacy
por: Minassian, Angela M., et al.
Publicado: (2011)

The Candidate TB Vaccine, MVA85A, Induces Highly Durable Th1 Responses
por: Tameris, Michele, et al.
Publicado: (2014)

Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2009)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2011)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
por: Pathan, Ansar A., et al.
Publicado: (2012)

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
por: Pepponi, Ilaria, et al.
Publicado: (2017)

TB vaccine development and the End TB Strategy: importance and current status
por: Fletcher, Helen A., et al.
Publicado: (2016)

TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development
por: Kaufmann, Stefan H. E., et al.
Publicado: (2017)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery()
por: Meyer, Joel, et al.
Publicado: (2013)

Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model
por: Pinpathomrat, Nawamin, et al.
Publicado: (2021)

Cholera Toxin Enhances Vaccine-Induced Protection against Mycobacterium Tuberculosis Challenge in Mice
por: Griffiths, Kristin L., et al.
Publicado: (2013)

Evaluation of Xpert(®) MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial
por: Bunyasi, Erick Wekesa, et al.
Publicado: (2015)

Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges
por: Morrison, Hazel, et al.
Publicado: (2023)

A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge
por: Stylianou, Elena, et al.
Publicado: (2023)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
por: Satti, Iman, et al.
Publicado: (2022)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
por: Stylianou, Elena, et al.
Publicado: (2019)

Clinical Development of New TB Vaccines: Recent Advances and Next Steps
por: Hatherill, Mark, et al.
Publicado: (2020)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
por: McShane, Helen
Publicado: (2011)

Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection
por: Tanner, Rachel, et al.
Publicado: (2020)

The TB vaccine development pathway – An innovative approach to accelerating global TB vaccine development
por: Roordink, Danielle, et al.
Publicado: (2021)

Improving Tuberculosis Vaccine Trial Efficiency: A Tough Nut to Crack
por: McShane, Helen
Publicado: (2023)

Next-Generation TB Vaccines: Progress, Challenges, and Prospects
por: Zhuang, Li, et al.
Publicado: (2023)

The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life
por: Naranbhai, Vivek, et al.
Publicado: (2014)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
por: Tanner, Rachel, et al.
Publicado: (2021)

World TB Day 2018: The Challenge of Drug Resistant Tuberculosis
por: Gupta-Wright, Ankur, et al.
Publicado: (2018)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response
por: Matsumiya, Magali, et al.
Publicado: (2014)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
por: Villarreal-Ramos, Bernardo, et al.
Publicado: (2014)

Why don’t we have an effective tuberculosis vaccine yet?
por: Davenne, Tamara, et al.
Publicado: (2016)

The next 10 years for tuberculosis vaccines: do we have the right plans in place?
por: Meyer, Joel, et al.
Publicado: (2013)

Evaluation of a Human BCG Challenge Model to Assess Antimycobacterial Immunity Induced by BCG and a Candidate Tuberculosis Vaccine, MVA85A, Alone and in Combination
por: Harris, Stephanie A., et al.
Publicado: (2014)

VALIDATE: Exploiting the synergy between complex intracellular pathogens to expedite vaccine research and development for tuberculosis, leishmaniasis, melioidosis and leprosy
por: Fletcher, Helen A., et al.
Publicado: (2018)

Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
por: Dockrell, Hazel M., et al.
Publicado: (2022)

Gene Expression and Cytokine Profile Correlate With Mycobacterial Growth in a Human BCG Challenge Model
por: Matsumiya, Magali, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g287gh35di4bcq4550npl583t1